Integral Health Asset Management
$2.4B 13F equity value
114 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Integral Health Asset Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 1,500,000 | $281M | 11.5% |
| INSM | INSMED INC | 1,600,000 | $171M | 7.0% |
| CYTK | CYTOKINETICS INC | 1,600,000 | $136M | 5.6% |
| CVS | CVS HEALTH CORP | 1,100,000 | $114M | 4.7% |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,000,000 | $81M | 3.3% |
| VERA | VERA THERAPEUTICS INC | 1,750,000 | $75M | 3.1% |
| AXSM | AXSOME THERAPEUTICS INC. | 300,000 | $73M | 3.0% |
| CAH | CARDINAL HEALTH INC | 300,000 | $71M | 2.9% |
| ROIV | ROIVANT SCIENCES LTD | 2,000,000 | $71M | 2.9% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 550,000 | $61M | 2.5% |
Track Integral Health Asset Management's 13F portfolio: $2.4B in reported holdings, 114 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}